This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Study design
This was a retrospective cohort study, carried out in a single centre. The choice of interventions was based on the attending surgeon's preference. The duration of the follow-up appears to have been until discharge from hospital. The follow-up ultrasound scans and the pulse examinations were performed 24 to 72 hours after the treatment to evaluate for thrombosis or recurrence.
Analysis of effectiveness
The principle (intention to treat or treatment completers only) used in the analysis of effectiveness was not explicitly specified. The clinical outcome measures were success rate, time to thrombosis, vascular laboratory time, severe pain, and complications. The study groups were comparable in terms of demographics and aneurysm sizes, (p>0.2).
Effectiveness results
The effectiveness results were as follows:
For the entire period, 25 of 40 pseudoaneurysms (63%) were treated successfully using the compression therapy (9 persistent aneurysms necessitated operation, and 6 were treated successfully with thrombin injection) versus 27 of 29 (93%) in the thrombin therapy.
The average time to thrombosis was 37 minutes for compression versus only seconds in the thrombin group (p<0.01).
The total vascular laboratory time for compression was 59 minutes per patient and 16 minutes per patient for thrombin injection.
Three patients in the compression group reported significant pain and requested that the procedure be aborted; no patients in the thrombin group had discomfort.
No complications were encountered in either form of treatment.
Clinical conclusions
The study found the percutaneous thrombin injection therapy to be a safe and more effective treatment method than compression. The authors believe that technical issues such as the localisation of the needle tip may limit the applicability of the thrombin injection to all patients.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis, and only individual health outcomes were reported.
Direct costs
Costs were not discounted due to the short time frame of the cost analysis. Some quantities were reported separately from the costs. Cost items were not reported separately. Cost analysis covered the costs of operative repair of femoral artery false aneurysms, hourly cost in the vascular laboratory, and cost of supplies. The perspective adopted in the cost analysis was that of the hospital. Average hospitalisation charges were reported for the study groups, but the average calculated cost per patient for treatment of a pseudoaneurysm was based on actual hospital costs in the study institution rather than charges. The price year was not given. The cost analysis did not cover physician fees. and the price year was not reported. The cost results may not be generalisable outside the study setting. It was noted that the study was not able to show an overall significant cost saving in total hospital expenditures between the two groups because of the large number of comorbid factors.
Other issues
Given the retrospective nature of the study design, and the lack of sensitivity analysis and statistical analysis of costs, the study results may need to be treated with some degree of caution. The issue of generalisability to other settings or countries was not addressed. Appropriate comparisons were made with other studies. The issue of the study sample being representative of the study population was not addressed other than by noting that the study sample was associated with a large number of comorbid factors.
Implications of the study
Ultrasound scan-guided thrombin injection therapy has become the authors' preferred initial treatment for all pseudoaneurysms that appear suitable. The authors continue to use compression in the cases in which the cavity is small, with an anterior simple neck, and in cases in which thrombin injection therapy fails. The authors thus believe that the two therapeutic methods are complementary.
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